Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: a phase I/II southwestern oncology group study

By Einstein A.B.   Wolf M.   Halliday K.R.   Miller G.J.   Hafermann M.   Lowe B.A.   Meyers F.J.   Leimert J.T.   Crawford E.D.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 652-657

Elsevier

Access to resources Recommend Favorite

A phase II trial of oral estramustine and oral etoposide in hormone refractory prostate cancer

By Pienta K.J.   Redman B.G.   Bandekar R.   Strawderman M.   Cease K.   Esper P.S.   Naik H.   Smith D.C.  

Urology, Vol. 50, Iss. 3, 1997-09 ,pp. : 401-407

Elsevier

Access to resources Recommend Favorite

Endoscopic resection of bladder cancer in patients receiving double platelet antiaggregant therapy

By Carmignani Luca  

Surgical Endoscopy, Vol. 25, Iss. 7, 2011-07 ,pp. : 2281-2287

Springer Publishing Company

Access to resources Recommend Favorite

Impact of a second transurethral resection on the staging of T1 bladder cancer

By Dalbagni G.   Herr H.W.   Reuter V.E.  

Urology, Vol. 60, Iss. 5, 2002-11 ,pp. : 822-824

Elsevier

Access to resources Recommend Favorite

Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trial

By Sarosdy M.F.   Lowe B.A.   Schellhammer P.F.   Lamm D.L.   Graham S.D.   Grossman H.B.   See W.A.   Peabody J.O.   Moon T.D.   Flanigan R.C.   Crawford E.D.   Morganroth J.  

Urology, Vol. 48, Iss. 1, 1996-07 ,pp. : 21-27

Elsevier

Access to resources Recommend Favorite